The authors suggested that MANF could suppress hepatocyte inflammation by inhibiting the NF-κB/Snail signaling pathway and reduce the invasive and migratory capacity of hepatocellular carcinoma cells by interfering with the hepatocyte epithelial-mesenchymal transition. The gene discussed is MANF; the disease is hepatocellular carcinoma.